rTMS on Diabetic Peripheral Neuropathic Pain
Launched by MIN CHEOL CHANG · Apr 4, 2021
Trial Information
Current as of May 09, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diabetes
- • neuropathic pain (stocking glove distribution) of a numeric rating scale (NRS) score of ≥3 (where 0 indicates no pain and 10 indicates the most intense pain imaginable) in the lower extremities
- • pain duration of ≥3 months
- • age between 21 and 80 years
- Exclusion Criteria:
- • presence of contraindications for TMS, such as a history of epileptic seizure, presence of metal in the skull, and presence of a cardiac pacemaker.
About Min Cheol Chang
Min Cheol Chang is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to ethical practices and rigorous scientific standards, the organization facilitates the development of new therapies across various therapeutic areas. Leveraging a network of experienced professionals and state-of-the-art resources, Min Cheol Chang aims to enhance patient outcomes through meticulously designed clinical trials that prioritize safety and efficacy. Their strategic partnerships and collaborative approach ensure the efficient progression of studies from initial phases to successful implementation in clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Daegu, , Korea, Republic Of
Patients applied
Trial Officials
Min Cheol Chang
Study Director
Yuengnam University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials